Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Kruse

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|November 9, 2012
Increased expression of toll-like receptor 4 and inflammatory cytokines, interleukin-6 in particular, in islets from a mouse model of obesity and type 2 diabetesMette Ladefoged, Karsten Buschard, Ann Maria Kruse Hansen
The Journal of Physiology|November 15, 2005
Neuronal responses to transient hypoglycaemia in the dorsal vagal complex of the rat brainstemRobert H Balfour, Ann Maria Kruse Hansen, Stefan Trapp
Journal of Medical Case Reports|December 15, 2021
Recurrent autoimmune hypophysitis treated with rituximab: a case reportMaria Kruse, Thomas Bastholm Olesen, Ljubo Markovic, et al.
The Journal of Biological Chemistry|May 19, 2016
Type II Turn of Receptor-bound Salmon Calcitonin Revealed by X-ray CrystallographyEva Johansson, Jakob Lerche Hansen, Ann Maria Kruse Hansen, et al.
Molecular Metabolism|May 24, 2018
Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificityArchita Agrawal, Sebastian Parlee, Diego Perez-Tilve, et al.
The Journal of Endocrinology|April 1, 2025
Deletion of GFRAL blunts weight lowering effects of FGF21 in female miceAlberte Silke Buch-Rasmussen, Helle Andersen, Christina Stage, et al.
Molecular Metabolism|July 9, 2022
Next generation GLP-1/GIP/glucagon triple agonists normalize body weight in obese micePatrick J Knerr, Stephanie A Mowery, Jonathan D Douros, et al.
Molecular Metabolism|November 18, 2022
Discovery of a potent GIPR peptide antagonist that is effective in rodent and human systemsBin Yang, Vasily M Gelfanov, Kimberley El, et al.
Journal of Medicinal Chemistry|July 3, 2024
NN1213 - A Potent, Long-Acting, and Selective Analog of Human AmylinKirsten Dahl, Kirsten Raun, Jakob Lerche Hansen, et al.
Cell Metabolism|December 2, 2025
Analog of prolactin-releasing peptide reduces body weight primarily through sustained fatty acid oxidation rather than hypophagiaClaire H Feetham, Sam Groom, Linu M John, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|November 9, 2012
Increased expression of toll-like receptor 4 and inflammatory cytokines, interleukin-6 in particular, in islets from a mouse model of obesity and type 2 diabetesMette Ladefoged, Karsten Buschard, Ann Maria Kruse Hansen
The Journal of Physiology|November 15, 2005
Neuronal responses to transient hypoglycaemia in the dorsal vagal complex of the rat brainstemRobert H Balfour, Ann Maria Kruse Hansen, Stefan Trapp
Journal of Medical Case Reports|December 15, 2021
Recurrent autoimmune hypophysitis treated with rituximab: a case reportMaria Kruse, Thomas Bastholm Olesen, Ljubo Markovic, et al.
The Journal of Biological Chemistry|May 19, 2016
Type II Turn of Receptor-bound Salmon Calcitonin Revealed by X-ray CrystallographyEva Johansson, Jakob Lerche Hansen, Ann Maria Kruse Hansen, et al.
Molecular Metabolism|May 24, 2018
Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificityArchita Agrawal, Sebastian Parlee, Diego Perez-Tilve, et al.
The Journal of Endocrinology|April 1, 2025
Deletion of GFRAL blunts weight lowering effects of FGF21 in female miceAlberte Silke Buch-Rasmussen, Helle Andersen, Christina Stage, et al.
Molecular Metabolism|July 9, 2022
Next generation GLP-1/GIP/glucagon triple agonists normalize body weight in obese micePatrick J Knerr, Stephanie A Mowery, Jonathan D Douros, et al.
Molecular Metabolism|November 18, 2022
Discovery of a potent GIPR peptide antagonist that is effective in rodent and human systemsBin Yang, Vasily M Gelfanov, Kimberley El, et al.
Journal of Medicinal Chemistry|July 3, 2024
NN1213 - A Potent, Long-Acting, and Selective Analog of Human AmylinKirsten Dahl, Kirsten Raun, Jakob Lerche Hansen, et al.
Cell Metabolism|December 2, 2025
Analog of prolactin-releasing peptide reduces body weight primarily through sustained fatty acid oxidation rather than hypophagiaClaire H Feetham, Sam Groom, Linu M John, et al.
Pageof 2